US FDA Continues Push For Rx-OTC Switches With New MaPP For Generics

 
• By Malcolm Spicer
  
The new MaPP applies only to drugs made available OTC through full switches. (Source: Shutterstock/Citeline)

More from Biosimilars & Generics

More from United States